Crossmark

HLA-DQB1*03:01 and HLA-DQA1*05:05 as key genetic determinants of infliximab response and immunogenicity in Japanese patients with inflammatory bowel disease

Crossref DOI link: https://doi.org/10.1007/s00535-026-02354-z

Published Online: 2026-02-06

Published Print: 2026-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Osaka, Ryuya

Naito, Takeo https://orcid.org/0000-0002-9744-7946
Khor, Seik-Soon

Kakuta, Yoichi

Kawai, Yosuke

Nagasaki, Masao

Meguro, Hiroshi

Iwaki, Hideya

Okamoto, Daisuke

Nagai, Hiroshi

Shimoyama, Yusuke

Moroi, Rintaro

Shiga, Hisashi

Kinouchi, Yoshitaka

Masamune, Atsushi
Funding

Funding for this research was provided by:

JSPS KAKENHI (23K15000)

Toshiba
License Information

Text and Data Mining valid from 2026-02-06

Version of Record valid from 2026-02-06
More Information

Article History

Received: 2 September 2025

Accepted: 25 January 2026

First Online: 6 February 2026

Declarations

:

: Nagasaki received research grants from Toshiba Corp. A.

Document is current

Any future updates will be listed below